ISTH 2022 Congress
Diagnostics and OMICs » Biomarkers of Thrombosis and Hemostasis
Theme Navigation
- ISTH 2022 Congress
- Diagnostics and OMICs
- Biomarkers of Thrombosis and Hemostasis
- Diagnostics and OMICs
-
Abstract Number: VPB0148
ADAMTS-13 activity and silent brain infarction in patients with non-ischemic dilated cardiomyopathy
-
Abstract Number: PB0147
Development of a microfluidic model to evaluate extracorporeal circuit material thrombogenicity
-
Abstract Number: PO0017
Essential Biomarkers for a Clinical Study of a Novel Allogeneic Cell Therapy for Acute Graft-versus-Host Disease
-
Abstract Number: PB0144
Expression of microRNAs related to platelet function and cardiovascular events in patients with stable coronary artery disease
-
Abstract Number: OC 17.1
Growth differentiation factor-15 is related to adverse prognosis in patients with polyvascular disease receiving dual antithrombotic therapy
-
Abstract Number: PB0143
Interferences in the dosage of D-dimer and variation between methodologies.
-
Abstract Number: PB0145
MRP-4 («Multidrug Resistance Protein-4) PROTEIN EXPRESSION IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) UNDER CHRONIC ASPIRIN TREATMENT
-
Abstract Number: PB0146
Obese patients show enhanced ex vivo collagen-induced thrombus formation in flowing human blood
-
Abstract Number: PB0142
Overall Haemostatic Potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
-
Abstract Number: LB 02.4
Platelets as Versatile Effectors of Thromboinflammation in Chronic Myeloproliferative Neoplasms
-
Abstract Number: PO0018
Reference Range Determination for the Novel T-TAS 01 AR Assay